New strategy to attack aggressive brain cancer shows promise
Time:2024-05-21 11:58:15 Source:styleViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Previous:Hall of Fame outfielder Ken Griffey Jr. to lead Indianapolis 500 field in Corvette pace car
Next:Verona confirms Serie A status for another year after beating Salernitana
You may also like
- Analysis: Larson enters conversation with Verstappen as best drivers in the world
- Inquiry slams UK authorities for failures that killed thousands in infected blood scandal
- Brazil replaces injured goalkeeper Ederson in Copa America squad
- Here comes the char
- Cruise worker 'murders newborn son on board ship': Shocked co
- Trump accepts a VP debate but wants it on Fox News. Harris has already said yes to CBS
- Rangers are undefeated at .500 to keep World Series champs from a losing record with Bochy
- Lynn Williams breaks NWSL goal
- Everybody may love Raymond, but Ray Romano loves Peter Boyle